Results 211 to 220 of about 46,487 (292)

Editorial: Enhancing therapeutic strategies: a focus on pharmacovigilance in new wave antidepressants and antipsychotics. [PDF]

Front Psychiatry
Vasiliu O, Manchia M, Noguchi Y, Mikellides G.   +3 more
europepmc   +1 more source

The Lived Experience of Delirium in a Critically Ill Child: A Narrative Study

Scandinavian Journal of Caring Sciences, Volume 40, Issue 2, June 2026.
ABSTRACT Background While the negative experience of intensive care delirium has been established in adults, paediatric delirium (PD) is increasingly being recognized internationally. Knowledge, however, is still lacking regarding the experience of delirium in critically ill children. Therefore, we wish to provide insight into the subjective experience
Rikke Louise Stenkjaer, Ingrid Egerod, Mala Moszkowicz, Erwin Ista, Suzanne Forsyth Herling   +4 more
wiley   +1 more source

THE NEW PARADIGM OF RECOVERY FROM SCHIZOPHRENIA: CULTURAL CONUNDRUMS OF IMPROVEMENT WITHOUT CURE [PDF]

, 2006
CARPENTER-SONG, ELIZABETH, JENKINS, JANIS H   +1 more
core  

Antipsychotic agents.

North Carolina medical journal, 1974
openaire   +1 more source

Prevalence and impact of prescribing cascades in community‐dwelling adults: Longitudinal analysis of the Irish longitudinal study on ageing (TILDA)

British Journal of Clinical Pharmacology, Volume 92, Issue 5, Page 1500-1508, May 2026.
Prescribing cascades occur when medication is prescribed to prevent/treat the adverse effects of another medication and may be intentional/unintentional. This study examines the prevalence of nine prescribing cascades (ThinkCascades) in The Irish Longitudinal StuDy on Ageing (TILDA).
Ann Sinéad Doherty, Rose Anne Kenny, Frank Moriarty, Fiona Boland, Barbara Clyne, Tom Fahey, Denis O' Mahony, Emma Wallace   +7 more
wiley   +1 more source

Impact of antipsychotics, antiparkinsonian drugs, and anthraquinone stimulant laxatives on severe constipation in patients with schizophrenia. [PDF]

PCN Rep
Nadaya T, Inaguma T, Nagao T, Ishida T.
europepmc   +1 more source

Cannabinoids and drug–drug pharmacokinetic interactions: Deciphering the risks

British Journal of Clinical Pharmacology, Volume 92, Issue 5, Page 1287-1308, May 2026.
The relationship between cannabinoids and mental health has become a major focus of scientific inquiry and public discourse. Cannabinoids are diverse chemical compounds from the Cannabis species that have been explored for their therapeutic applications in treating chronic pain, psychiatric and neurological conditions, such as depression, schizophrenia,
Paraskevi Papakyriakopoulou, Georgia Valsami, Georgios Ismailos   +2 more
wiley   +1 more source

Characterization of the Adverse Drug Reactions Associated with Psychotropic Medications Based on a Spontaneous Reporting Systems Database: A Retrospective Analysis. [PDF]

Risk Manag Healthc Policy
Eltorki Y, Abdallah O, Alkudsi Z, Elamin W, Gharaibeh A, Mustafa M, Abu Shameh N, Riaz S, Mahran I, Al-Khuzaei N, Wadoo O, Zolezzi M.   +11 more
europepmc   +1 more source

Trends in Antipsychotic Drug Use in the United States, 2000-2016. [PDF]

Pharmacy (Basel)
Haddad N, Farhat N, Go J, Chen Y, Gravel CA, Momoli F, Mattison DR, McNair D, Alami A, Krewski D.   +9 more
europepmc   +1 more source